Point72 Asset Management, L.P.

Holdings History for Avalo Therapeutics, Inc. - COMMON STOCK (AVTX)

Symbol: AVTX on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Shares Owned: 627,502 shares
Security Ownership %: 3.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Point72 Asset Management, L.P. ownership in Avalo Therapeutics, Inc. COMMON STOCK (AVTX)

17 Feb 2026 - Point72 Asset Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 627,502 shares of Avalo Therapeutics, Inc. COMMON STOCK (AVTX). This represents 3.5% ownership of the company. In their previous filing dated 14 Nov 2025, Point72 Asset Management, L.P. had reported owning 1,053,983 shares, indicating a decrease of +40%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Point72 Asset Management, L.P.	3.5%	-56%	$10,636,159	627,502	-426,481	-40%	$16.95	13G/A	31 Dec 2025	17 Feb 2026, 16:33
Point72 Asset Management, L.P.	8%	+52%	$13,396,124	1,053,983	+465,351	+79%	$12.71	13G/A	30 Sep 2025	14 Nov 2025, 16:11
Point72 Asset Management, L.P.	5.4%		$2,813,661	588,632			$4.78	13G	04 Aug 2025	05 Aug 2025, 16:58

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.02%	-0.01%	$11,395,436	627,502	-426,481	-40%	$18.16	Q4 2025
30 Sep 2025		0.03%	+0.03%	$13,396,124	1,053,983	+1,053,983	NEW	$12.71	Q3 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.